0001477932-23-004119.txt : 20230531 0001477932-23-004119.hdr.sgml : 20230531 20230531162114 ACCESSION NUMBER: 0001477932-23-004119 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20230525 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cosmos Health Inc. CENTRAL INDEX KEY: 0001474167 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 270611758 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41308 FILM NUMBER: 23981277 BUSINESS ADDRESS: STREET 1: 141 W. JACKSON BLVD STREET 2: SUITE 4236 CITY: CHICAGO STATE: IL ZIP: 60604 BUSINESS PHONE: 312-536-3102 MAIL ADDRESS: STREET 1: 141 W. JACKSON BLVD STREET 2: SUITE 4236 CITY: CHICAGO STATE: IL ZIP: 60604 FORMER COMPANY: FORMER CONFORMED NAME: Cosmos Holdings Inc. DATE OF NAME CHANGE: 20140106 FORMER COMPANY: FORMER CONFORMED NAME: PRIME ESTATES & DEVELOPMENTS INC DATE OF NAME CHANGE: 20091008 8-K 1 cosm_8k.htm FORM 8-K cosm_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 25, 2023

 

Cosmos Health Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-54436 

 

27-0611758 

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

141 West Jackson Blvd, Suite 4236,

Chicago, Illinois

 

60604

(Address of principal executive offices) 

 

(Zip Code)

 

Registrant’s telephone number, including area code (312) 865-0026

 

Cosmos Health Inc.

(Former name or former address, if changed since last report.)

 

Title of Each Class

 

Trading

Symbol

 

Name of Each Exchange

On Which Registered

Common Stock, $.001 par value

 

COSM

 

Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 8.01 OTHER EVENTS

 

On May 25, 2023, Cosmos Health Inc. (the “Company”) entered into a binding letter of intent to acquire (the “Acquisition”) Docpharm GmbH (“Docpharm”), an established German pharmaceutical distributor. Established in 1995, Docpharm is an ISO-certified and licensed under GDP (Good Distribution Practices) pharmaceutical company that imports and distributes medicines, pharmaceutical products and medical devices.

 

The purchase price for the Acquisition is €800,000 in cash to be paid to the owners of Docpharm. An additional €1,000,000 will be provided by a basic credit line with a designated bank account within ten (10) days of closing of the Acquisition.

 

The Company will negotiate in good faith customary service agreements equal to or more favorable with the current service agreements with the managing directors. The closing of the Acquisition is subject to: (a) satisfactory completion of due diligence by the Company; (b) execution of a definitive purchase agreement; (c) approval of the Acquisition by the Company’s and GmbH’s Boards of Directors and the stockholders of GmbH; (d) confirmation that GmbH’s financial statements can be audited in accordance with the PCAOB and SEC rules and regulations; and (e) customary closing conditions. The Company was given exclusivity until July 15, 2023 to acquire GmbH.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits 

 

Number

 

 

10.1

 

Binding Letter of Intent dated May 25, 2023 by and among Cosmos Health Inc. and Docpharm GmbH and Dr. Mathias Krebs.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

 

 
2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COSMOS HEALTH INC.

 

 

 

 

Date: May 31, 2023

By:

/s/ Georgios Terzis

Georgios Terzis

 

Chief Financial Officer

 

 

 
3

 

 EX-10.1 2 cosm_ex101.htm BINDING LETTER cosm_ex101.htm

EXHIBIT 10.1

 

BINDING

 

LETTER OF INTENT (LOI)

 

This Letter of Intent (“LOI”) sets forth the terms and conditions for a proposed acquisition and financing by Cosmos Health Inc. (“Cosmos”), a corporation organized under the laws of the State of Nevada, with Company I.R.S number (27-0611758),located at 141 West Jackson Boulevard, Suite 4236, Chicago, IL 60604, of Docpharm Gmbh. (the “Company” or “docpharm®”), a company organized under the laws of Germany with Company registration number HRB 782055, located at Borsigstrasse 3, 71263, Weil der Stadt, Germany.

 

The Company is an ISO certified and licensed under GDP (Good Distribution Practices) pharmaceutical company that imports and distributes medicines, pharmaceutical products and medical devices. Moreover, the Company holds a wholesaler license issued from the local government of Baden Württemberg and owns a substantial number of medicine and medical device licenses, that enable the company to be engaged in the distribution business of pharmaceutical products within Germany (all licenses and related permits and authorizations, collectively, the “Assets”).

 

This LOI is intended to be a binding agreement setting out the basic terms of the acquisition and financing and shall be superseded by a definitive Sales and Purchase Agreement (“SPA”) and related transaction documents as described herein (“Transaction Documents”) entered by the parties governing the Transaction (as defined below).

 

Proposed Transaction:   

Cosmos shall, directly or indirectly through a subsidiary, acquire all of the outstanding shares of capital stock in the Company together with all of its Assets (the “Shares”), free and clear of all encumbrances, in exchange for cash, payable (or issued) to the Company or other controlling entity or person (the “Transaction”). Cosmos shall further provide funds for financing the growth and working capital of the company according to the business-plan, which has to be agreed among both parties.

 

 

Due Diligence: 

Further to the documents and information already shared with Cosmos following the Confidentiality Agreement signed by the Parties and after the date of this LOI, the Company’s management shall allow Cosmos and its advisors full access to the Company’s facilities, records, key employees and advisors for the purpose of completing Cosmos’s due diligence review. The due diligence investigation will include, but is not limited to, a complete review of the Company's financial, legal, tax, environmental, intellectual property and labor records and agreements, and any other matters as Cosmos’s accountants, tax and legal counsel, and other advisors deem necessary.  For the avoidance of doubt, the due diligence might include a  PCAOB audit of the Company.

    

 
1

 

 

SPA Purchase Price:    

Cosmos, the Company and its owners agree that the purchase price for the acquisition of Shares and Company Assets shall be a fixed amount in cash of EUR 800,000 paid to the Company’s owners , as defined in Annex 1. 

 

 

Financing :    

Cosmos agrees to provide a financing facility at the amount of EUR 1,000,000 available at Company’s bank account, as defined in Annex 1. 

 

 

Conditions:   

Cosmos’s obligation to close the proposed Transaction via the execution of the definitive SPA and other Transaction Documents will be subject to customary conditions; including, but not limited to: (a) Cosmos’s satisfactory completion of due diligence, (b) the approval of the Transaction by the Board of Directors and/or the stockholders of Cosmos and the Company, (c) confirmation from Cosmos’s auditors that the financial statements of the Company  can be audited in accordance with PCAOB and SEC rules and regulations.

 

 

Management Condition:  

Parties agreed that certain current managers of the Company will remain managing directors of the Company. Parties will negotiate in good faith customary service agreements for the managing directors, whereby the Parties agree that the economic terms of such new agreements shall be equal or more favorable for the managing directors compared to their current service agreements.

 

 

Definitive Agreements:  

In addition to the provisions specifically described herein, the definitive agreements relating to the Transaction will contain standard representations, warranties, survival periods, indemnification, limits on indemnification, covenants, termination rights and other provisions appropriate for a transaction of the type contemplated herein, which may include additional restrictions on the transfers of any newly issued Cosmos stock.

  

 
2

 

 

Exclusivity:     

In consideration of the expenses that Cosmos has incurred and will incur in connection with the proposed Transaction, the Company and its owners agree that until the earlier of (a) December 31, 2023 or (ii) such time as this LOI has terminated in accordance with the provisions of the Termination section (such period, the “Exclusivity Period”), neither the Company nor any of its representatives, officers, employees, directors, agents, owners, stockholders, subsidiaries or affiliates (the “Seller Group”) shall initiate, solicit, entertain, negotiate, accept or discuss, directly or indirectly, any proposal or offer from any person or group of persons other than Cosmos and its affiliates (an “Acquisition Proposal”) to acquire all or any significant part of the business and properties, capital stock or capital stock equivalents of the Company, whether by merger, purchase of stock, purchase of assets, tender offer or otherwise, or provide any non-public information to any third party in connection with an Acquisition Proposal or enter into any agreement, arrangement or understanding requiring it to abandon, terminate or fail to consummate the Transaction with Cosmos. The Company agrees to immediately notify Cosmos if any member of the Seller Group receives any indications of interest, requests for information or offers in respect of an Acquisition Proposal, and will communicate to Cosmos in reasonable detail the terms of any such indication, request or offer, and will provide Cosmos with copies of all written communications relating to any such indication, request or offer. Immediately upon execution of this LOI, the Company and its owners shall, and shall cause the Seller Group to, terminate any and all existing discussions or negotiations with any person or group of persons other than Cosmos and its affiliates regarding an Acquisition Proposal. The Company and its owners represent that no member of the Seller Group is party to or bound by any agreement with respect to an Acquisition Proposal other than under this LOI.

 

 

Expenses:  

Cosmos agrees that the audit and due diligence shall be conducted at its sole expense.

 

 

Confidentiality:  

The parties acknowledge that Cosmos is publicly traded on the U.S. NASDAQ (ticker symbol: COSM), and this LOI or a respective press release may be published or otherwise filed with the Securities and Exchange Commission. Any other obligations for non-disclosure shall be governed by a separate agreement between the parties.

 

 

Expiration; Termination:  

This LOI will remain in effect until 11:59 PM, New York time, on September 30, 2023, unless earlier terminated by the mutual written agreement of the parties.

 

 
3

 

 

Governing Law; Forum    

This LOI shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to any choice or conflict of law provision or rule (whether of the State of New York or any other jurisdiction) that would cause the application of laws of any jurisdiction other than those of the State of New York.

 

 

 

The parties hereby consent to the concurrent jurisdiction exclusive jurisdiction of the courts of the State of New York and the United States located in New York County, New York in connection with any suit, action or proceeding arising out of or relating in any manner to this LOI, and each of the parties further irrevocably agree to waive any objection to the venue of any such suit or proceeding in either court, or to in personam jurisdiction.

 

 

Miscellaneous:   

This LOI may be executed in counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one agreement. Transmission of signed originals by electronic version (either as PDF versions or DocuSign) shall be deemed as an exchange of originals.  The headings of the various sections of this LOI have been inserted for reference only and shall not be deemed to be a part of this LOI.

 

 

 

This LOI contains the entire agreement and understanding between the parties hereto with respect to the subject matter hereof, and supersedes all prior and contemporaneous agreements, understandings, inducements and conditions, express or implied, oral or written, of any nature whatsoever with respect to the subject matter hereof. The express terms hereof control and supersede any course of performance and/or usage of the trade inconsistent with any of the terms hereof.

 

 

Third Party Beneficiaries:  

Except as specifically set forth or referred to herein, nothing herein is intended or shall be construed to confer upon any person or entity other than the parties and their successors or assigns, any rights or remedies under or by reason of this LOI.

 

[no further text on this page]

 

 
4

 

 

 

If you agree with the terms set forth above and desire to proceed with the proposed Transaction on that basis, please sign this LOI in the space provided below.

 

Dated: May 24th, 2023

 

  COSMOS HEALTH INC.
       
By: /s/ Grigorios Siokas

 

Name: 

Grigorios Siokas  
  Title:    Director and CEO  

  

Agreed and Accepted:

 

Docpharm Gmbh.

 

By: /s/ Dr. Mathias Krebs                                                 

Name: Dr. Mathias Krebs

Title:   President & CEO       

 

Company Owners

 

Healthcare & Pharma Holding GmbH

 

By: /s/ Hartmut Muller

Name:  Hartmut Muller, CEO

 

Dr. Mathias Krebs

 

By:  /s/ Dr. Mathias Krebs

 

 
5

 

 

Annex 1

 

SPA

 

Paid in Cash : EUR 800,000

 

1. The amount of EUR 800,000 (acquisition price) will be paid in cash into a designated bank account upon the signing of the SPA between Cosmos and the Company Owners.

 

Provision of funds: EUR 1,000,000

 

2. The amount of €1,000,000 (financing) will be provided by a basic credit line onto a designated bank account within 10 days of the signing and the closing of the SPA between Cosmos and the Company Owners.

 

[no further text on this page]

 

 
6

 

 

 EX-101.SCH 3 cosm-20230525.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 cosm-20230525_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Incorporation State Country Code Entity Tax Identification Number Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity File Number Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name EX-101.CAL 5 cosm-20230525_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 cosm-20230525_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 cosm-20230525_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover
May 25, 2023
Cover [Abstract]  
Entity Registrant Name Cosmos Health Inc.
Entity Central Index Key 0001474167
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date May 25, 2023
Entity Incorporation State Country Code NV
Entity Tax Identification Number 27-0611758
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity File Number 000-54436
Entity Address Address Line 1 141 West Jackson Blvd
Entity Address Address Line 2 Suite 4236
Entity Address City Or Town Chicago
Entity Address State Or Province IL
Entity Address Postal Zip Code 60604
City Area Code 312
Local Phone Number 865-0026
Security 12b Title Common Stock, $.001 par value
Trading Symbol COSM
Security Exchange Name NASDAQ
XML 9 cosm_8k_htm.xml IDEA: XBRL DOCUMENT 0001474167 2023-05-25 2023-05-25 iso4217:USD shares iso4217:USD shares 0001474167 false 8-K 2023-05-25 Cosmos Health Inc. NV 000-54436 27-0611758 141 West Jackson Blvd Suite 4236 Chicago IL 60604 312 865-0026 Common Stock, $.001 par value COSM NASDAQ false false false false false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 1 23 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://cosm.com/role/Cover Cover Cover 1 false false All Reports Book All Reports cosm_8k.htm cosm-20230525.xsd cosm-20230525_cal.xml cosm-20230525_def.xml cosm-20230525_lab.xml cosm-20230525_pre.xml cosm_ex101.htm http://xbrl.sec.gov/dei/2022 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "cosm_8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "calculationLink": { "local": [ "cosm-20230525_cal.xml" ] }, "definitionLink": { "local": [ "cosm-20230525_def.xml" ] }, "inline": { "local": [ "cosm_8k.htm" ] }, "labelLink": { "local": [ "cosm-20230525_lab.xml" ] }, "presentationLink": { "local": [ "cosm-20230525_pre.xml" ] }, "schema": { "local": [ "cosm-20230525.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "cosm", "nsuri": "http://cosm.com/20230525", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "cosm_8k.htm", "contextRef": "From2023-05-25to2023-05-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://cosm.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "cosm_8k.htm", "contextRef": "From2023-05-25to2023-05-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://cosm.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001477932-23-004119-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-23-004119-xbrl.zip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